Todd Miller
Family Medicine · Wichita, KSNPI 1558479675
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 424 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,930 and has fallen 97.6% since, to $46 in 2023. Among family medicine clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $14.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$813
- AbbVie$758
- Amgen$669
- Pfizer$589
- Boehringer Ingelheim$572
- Novo Nordisk$311
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,020100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $813 |
| AbbVie(2 entities) | 59 | $758 |
| Amgen | 49 | $669 |
| Pfizer | 59 | $589 |
| Boehringer Ingelheim | 22 | $572 |
| Novo Nordisk | 31 | $311 |
| Johnson & Johnson | 30 | $306 |
| Amarin Pharma, Inc. | 18 | $236 |
| Astellas Pharma US Inc | 14 | $185 |
| Merck | 11 | $183 |
| Esperion Therapeutics, Inc. | 6 | $159 |
| Biohaven Pharmaceutical Holding Company Ltd. | 17 | $148 |
| Biohaven Pharmaceuticals, Inc. | 22 | $134 |
| Eisai Inc. | 8 | $124 |
| Bayer | 5 | $93 |
| Sunovion Pharmaceuticals Inc. | 8 | $92 |
| Daiichi Sankyo Inc. | 7 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $78 |
| Lilly USA, LLC | 5 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Abbott | 3 | $40 |
| Medtronic | 2 | $40 |
| Nevro Corp. | 1 | $34 |
| Novartis | 2 | $33 |
| Pacira Therapeutics, Inc. | 2 | $29 |
| VBI Vaccine (delaware) Inc. | 1 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Genentech USA, Inc. | 2 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Shire North American Group Inc | 1 | $15 |
| Apria Healthcare LLC | 1 | $15 |
| Electromed, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,025 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.